Unknown OBSERVATIONAL NCT03217799

Noninvasive Measurement of Blood Coagulation

Sponsor: Meir Medical Center

Conditions Anticoagulant Overdosage Anticoagulants; Increased Blood Clot Blood Coagulation Disorder Coagulation Disorder

Interventions Measurement of coagulability of blood

Updated 7 times since 2017 Last updated: Jul 16, 2017 Started: Aug 31, 2017 Primary completion: Dec 31, 2018 Completion: Jul 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03217799, this observational or N/A phase trial focuses on Anticoagulant Overdosage and Anticoagulants; Increased and remains ongoing. Sponsored by Meir Medical Center, it has been updated 7 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Aug 2019 — Jan 2021 [monthly]

Unknown Status

Status: Not Yet Recruiting → Unknown Status
Jun 2018 — Aug 2019 [monthly]

Not Yet Recruiting

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Not Yet Recruiting

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Meir Medical Center

Data source: Meir Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.